Molecular Mechanisms of Flow-dependent Arterial Remodeling in Peripheral Arterial Disease
Molecular Mechanisms of Flow-dependent Arterial Remodeling in Peripheral Arterial Disease
批准号:
10453472
负责人:
LUKE Packard BREWSTER
金额:
$72.65万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-01 至 2024-07-31
关键词:
AffectAgingAnimal ModelAnimalsArterial Fatty StreakArteriesAtherosclerosisBiologyBiomechanicsBlood VesselsBlood flowCardiovascular DiseasesCardiovascular systemCollagen GeneControl GroupsCritical PathwaysDataDepositionDiseaseDisease ProgressionDisease modelElastinEndothelial CellsEnvironmentFBLN5 geneFemaleFibrosisFunctional disorderGene ExpressionGoalsHealthHigh Fat DietHistologyHumanIn VitroInfectionKnock-outKnockout MiceLeadLongevityMechanicsMediatingMediator of activation proteinMedicalMolecularMolecular ProfilingMolecular TargetMusNatural HistoryPathologicPathway interactionsPatientsPeptidesPeripheral arterial diseasePopulationResearchRiskRoleSeveritiesSignal PathwaySignal TransductionSurgical FlapsTamoxifenTestingTherapeuticThrombospondin 1TimeTissuesTransforming Growth Factor betaTranslatingTranslationsUp-RegulationWorkage relatedagedarterial remodelingarterial stiffnessclinically relevantconditional knockoutconnective tissue growth factorhuman femalehuman tissueimprovedin vitro Assayin vitro testingin vivoin vivo Modelin vivo evaluationknockout animalmalemortalitymultidisciplinarynovelprematureresponseshear stress
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Due to both aging and the improved longevity of patients with cardiovascular disease, the US population is at
an ever-increasing risk of developing peripheral arterial disease. Patients with peripheral arterial disease have
stiffened arteries, and peripheral arterial disease doubles patients' cardiovascular mortality. Importantly arterial
stiffening is thought to be reversible. While there are a number of factors that lead to atherosclerosis, we
propose that there are unique molecular signatures in arteries of patients with PAD that are related to the
stiffness and flow conditions of these arteries. We have identified an important role for thrombospondin-1 in
these conditions. Here we will identify and test the modifiability of these pathways using in vitro and in vivo
models of PAD conditions. In order to test translation of this work, human tissue will be used to test critical
findings. Positive results will be useful in developing targeted strategies that disrupt these pathways and
improve arterial health in our patients.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.jvs.2018.05.223
发表时间:
2018-12
期刊:
Journal of vascular surgery
影响因子:
4.3
作者:
[Chadid T, Morris A, Surowiec A, Robinson S, Sasaki M, Galipeau J, Pollack BP, Brewster LP]
通讯作者:
Brewster LP
DOI:
10.1097/xcs.0000000000000554
发表时间:
2023-04-01
期刊:
Journal of the American College of Surgeons
影响因子:
5.2
作者:
[]
通讯作者:
Search Engines to Capture Missing Deaths From Institutional Data Warehouse.
搜索引擎从机构数据仓库中捕获失踪死亡人数。
DOI:
10.1016/j.jss.2023.09.065
发表时间:
2024
期刊:
The Journal of surgical research
影响因子:
--
作者:
[Dayal,YashS, Foster,DennisG, Hao,Yilun, Bennett,SashaG, Brewster,LukeP]
通讯作者:
Brewster,LukeP
Vascular calcification: a left-handed compliment for aging.
血管钙化:对衰老的左手恭维。
DOI:
10.1152/ajpheart.00300.2021
发表时间:
2021
期刊:
American journal of physiology. Heart and circulatory physiology
影响因子:
--
作者:
[Brewster,LukeP]
通讯作者:
Brewster,LukeP
Rationale and design of the granulocyte-macrophage colony stimulating factor in peripheral arterial disease (GPAD-3) study.
外周动脉疾病中粒细胞-巨噬细胞集落刺激因子 (GPAD-3) 研究的基本原理和设计。
DOI:
10.1016/j.cct.2020.105975
发表时间:
2020
期刊:
Contemporary clinical trials
影响因子:
2.2
作者:
[Mehta,Anurag, Mavromatis,Kreton, Ko,Yi-An, Rogers,StevenC, Dhindsa,DevinderS, Goodwin,Cydney, Patel,Risha, Martini,MohammadA, Prasad,Mahadev, Mokhtari,Ali, Hesaroieh,IrajG, Frohwein,StephenC, Kutner,MichaelH, Harzand,Arash, Wells,Brya]
通讯作者:
Wells,Brya
Pilot Investigation of Ewing Amputation in Veterans with Peripheral Arterial Disease Undergoing Below Knee Amputation
-
批准号:10707110
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:LUKE Packard BREWSTER
-
依托单位:
Molecular Repair of Diabetic Mesenchymal Stem Cells (dMSC) for Peripheral Arterial Disease
-
批准号:10436770
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:LUKE Packard BREWSTER
-
依托单位:
Molecular Repair of Diabetic Mesenchymal Stem Cells (dMSC) for Peripheral Arterial Disease
-
批准号:10045514
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:LUKE Packard BREWSTER
-
依托单位:
Molecular Repair of Diabetic Mesenchymal Stem Cells (dMSC) for Peripheral Arterial Disease
-
批准号:10553638
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:LUKE Packard BREWSTER
-
依托单位:
Molecular Mechanisms of Flow-dependent Arterial Remodeling in Peripheral Arterial Disease
-
批准号:9976573
-
项目类别:
-
资助金额:$75.22万
-
财政年份:2018
-
负责人:LUKE Packard BREWSTER
-
依托单位:
Molecular Mechanisms of Flow-dependent Arterial Remodeling in Peripheral Arterial Disease
-
批准号:10226978
-
项目类别:
-
资助金额:$73.69万
-
财政年份:2018
-
负责人:LUKE Packard BREWSTER
-
依托单位:
Molecular Mechanisms of Flow-dependent Arterial Remodeling in Peripheral Arterial Disease
-
批准号:9751378
-
项目类别:
-
资助金额:$77.7万
-
财政年份:2018
-
负责人:LUKE Packard BREWSTER
-
依托单位:
Molecular Mechanism of Disturbed Flow in Arterial Stiffening
-
批准号:8829325
-
项目类别:
-
资助金额:$10.36万
-
财政年份:2014
-
负责人:LUKE Packard BREWSTER
-
依托单位:
Molecular Mechanism of Disturbed Flow in Arterial Stiffening
-
批准号:8700928
-
项目类别:
-
资助金额:$10.36万
-
财政年份:2014
-
负责人:LUKE Packard BREWSTER
-
依托单位:
Molecular Mechanism of Disturbed Flow in Arterial Stiffening
-
批准号:9212681
-
项目类别:
-
资助金额:$16.08万
-
财政年份:2014
-
负责人:LUKE Packard BREWSTER
-
依托单位:
Vascular Healing with VEGF-Collagen Binding Chimera
-
批准号:6943982
-
项目类别:
-
资助金额:$5.34万
-
财政年份:2004
-
负责人:LUKE Packard BREWSTER
-
依托单位:
Vascular Healing with VEGF-Collagen Binding Chimera
-
批准号:6837758
-
项目类别:
-
资助金额:$5.23万
-
财政年份:2004
-
负责人:LUKE Packard BREWSTER
-
依托单位:
海外基金